MX9300409A - Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. - Google Patents

Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.

Info

Publication number
MX9300409A
MX9300409A MX9300409A MX9300409A MX9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A
Authority
MX
Mexico
Prior art keywords
substituted
tetrahidrobenzoazepinonas
hexahidroazepinonas
tetrahydrobenzoazepinones
haxahydroazepinones
Prior art date
Application number
MX9300409A
Other languages
English (en)
Spanish (es)
Inventor
John A Lowe Iii
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9300409A publication Critical patent/MX9300409A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9300409A 1992-01-27 1993-01-26 Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. MX9300409A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
MX9300409A true MX9300409A (es) 1993-07-01

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300409A MX9300409A (es) 1992-01-27 1993-01-26 Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.

Country Status (19)

Country Link
EP (1) EP0625145A1 (de)
JP (1) JPH07503465A (de)
KR (1) KR950700257A (de)
CN (1) CN1074903A (de)
AU (1) AU3276193A (de)
BR (1) BR9207071A (de)
CA (1) CA2117367A1 (de)
CZ (1) CZ391092A3 (de)
FI (1) FI943513A0 (de)
HU (1) HUT70496A (de)
IL (1) IL104472A0 (de)
MX (1) MX9300409A (de)
NO (1) NO942775L (de)
NZ (1) NZ245759A (de)
RU (1) RU94038063A (de)
TW (1) TW213901B (de)
WO (1) WO1993015059A1 (de)
YU (1) YU4393A (de)
ZA (1) ZA93582B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
DK0711283T3 (da) * 1993-07-26 1999-11-22 Pfizer Tetrahydro-1H-benzazepinoner og hexahydroazepinoner som selektive cholecystokinin-B-receptorantagonister
ATE206402T1 (de) * 1993-11-22 2001-10-15 Merck & Co Inc 3-acylaminobenzazepine
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
MX9702507A (es) * 1994-10-04 1997-07-31 Pfizer Nuevos intermedios y procedimientos para preparar antagonistas cck.
IL115589A0 (en) 1994-10-14 1996-01-19 Glaxo Spa Use of cck-b antagonists in pharmaceutical compositions
DE10153348A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (de) * 1984-06-26 1988-10-26 Merck & Co. Inc. Kondensierte Benzo-Laktame und deren pharmazeutische Zusammensetzungen
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (de) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolaktam-Verbindungen und deren pharmazeutische Verwendungen
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
TW213901B (de) 1993-10-01
HU9402195D0 (en) 1994-09-28
FI943513A (fi) 1994-07-26
YU4393A (sr) 1996-01-09
IL104472A0 (en) 1993-05-13
RU94038063A (ru) 1996-05-27
EP0625145A1 (de) 1994-11-23
CA2117367A1 (en) 1993-08-05
NO942775D0 (no) 1994-07-26
KR950700257A (ko) 1995-01-16
HUT70496A (en) 1995-10-30
WO1993015059A1 (en) 1993-08-05
JPH07503465A (ja) 1995-04-13
CZ391092A3 (en) 1994-01-19
BR9207071A (pt) 1995-12-05
CN1074903A (zh) 1993-08-04
FI943513A0 (fi) 1994-07-26
NO942775L (no) 1994-09-20
ZA93582B (en) 1994-07-27
AU3276193A (en) 1993-09-01
NZ245759A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
DE3853566T2 (de) Formulierungen von Tetrazyklinverbindungen mit kontrollierter Freisetzung.
DK20892A (da) Seksuelt hjaelpemiddel
LV5824A4 (lv) Cilveku psihozes arstesanas panemiens
MY111201A (en) New imidazopyridines
FI934971A0 (fi) Anlaeggning foer foerbraenning av spraengaemnen
KR890700313A (ko) 살균 조성물
MX9101439A (es) Composiciones organicas de silicio
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
NO903148D0 (no) Hemoreguleringspeptider.
MX9300409A (es) Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.
FI930621A0 (fi) Bifenylsubstituerade kinolinderivat
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
ES2090530T3 (es) Produccion de peces mejorada.
ES2012314A4 (es) Tratamiento de composiciones precursoras de poliamida.
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
NO982562D0 (no) Sammensetning for behandling av smerte
DE689838T1 (de) Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat
ES2167942T3 (es) Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.
ITMI910967V0 (it) Regolo per la determinazione dell'intensita' del dolore
KR910009110U (ko) 방향용 양초의 구조
DK459286D0 (da) Terapeutisk komposition
ES292771Y (es) Anillo terapeutico
BR6702259U (pt) Canteiradeira de laminas